{
  "schema_version": "pdp_json_v1",
  "peptide": {
    "canonical_name": "MOTS-c",
    "short_name": "MOTS-c",
    "aliases": [
      "motsc"
    ],
    "classification": {
      "category": "investigational_human",
      "needs_prescription": false,
      "notes": "Classification describes what MOTS-c is and the general domain where it appears."
    },
    "status": {
      "category": "investigational_human",
      "jurisdiction": "GLOBAL",
      "last_reviewed": "2026-01-18",
      "human_use_note": "This entry summarizes how the compound is discussed/used in the real world without endorsing use or providing instructions."
    },
    "structure": {
      "sequence_oneletter": "",
      "amino_acid_seq": "",
      "molecular_formula": "",
      "molecular_weight": null,
      "structure_image_url": ""
    },
    "risk": {
      "current_score": 5,
      "severity": "moderate",
      "likelihood": "possible",
      "evidence_grade": "mechanistic_only",
      "developmental_risk": true,
      "unknowns_penalty": true,
      "rationale": "Risk rating is conservative and reflects known uncertainties, evidence limitations, and potential for non-obvious harms."
    },
    "sections": {
      "overview": [
        {
          "claim_type": "overview",
          "title": "What it is",
          "population_group": "general",
          "confidence": "unknown",
          "evidence_grade": "mechanistic_only",
          "text": "What it is and why it is studied are summarized here in a conservative, evidence-bounded way.",
          "evidence_refs": [
            "E1",
            "E2",
            "E3",
            "E4",
            "E5"
          ]
        }
      ],
      "use_cases": [],
      "mechanism": [],
      "human_effects": [],
      "preclinical_effects": [],
      "hypothesized_effects": [],
      "time_dynamics": [],
      "risks": [],
      "contraindications": [],
      "monitoring": [],
      "observed_exposure_ranges": [
        {
          "route": "",
          "unit": "",
          "min": null,
          "max": null,
          "frequency": "",
          "duration": "",
          "population_group": "general",
          "notes": "Descriptive only. Observed in studies; not instructions.",
          "evidence_refs": []
        }
      ],
      "developmental_risk_block": [
        {
          "claim_type": "risk",
          "population_group": "adolescent",
          "confidence": "unknown",
          "evidence_grade": "mechanistic_only",
          "text": "Developmental risk is flagged due to limited adolescent data and uncertain long-term effects. Endocrine, growth, neurodevelopmental, and metabolic setpoints may be sensitive to perturbation. This section is descriptive only; uncertainty is explicitly acknowledged.",
          "evidence_refs": []
        }
      ],
      "interaction_summary": []
    },
    "interactions": {
      "drug_classes": [],
      "supplement_classes": [],
      "peptides": []
    },
    "evidence": [
      {
        "source_id": "E1",
        "source_type": "journal_article",
        "evidence_grade": "animal",
        "title": "A 16-amino-acid peptide named MOTS-c regulates insulin sensitivity and metabolic homeostasis",
        "year": 2015,
        "url": "https://pubmed.ncbi.nlm.nih.gov/25738459/",
        "notes": "Discovery/characterization (animal + cellular). Mechanism framing only.",
        "id": "E1"
      },
      {
        "source_id": "E2",
        "source_type": "journal_article",
        "evidence_grade": "animal",
        "title": "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis",
        "year": 2021,
        "url": "https://pubmed.ncbi.nlm.nih.gov/33473109/",
        "notes": "Animal study; does not establish human efficacy.",
        "id": "E2"
      },
      {
        "source_id": "E3",
        "source_type": "journal_article",
        "evidence_grade": "human_observational",
        "title": "Effect of aerobic and resistance exercise on the mitochondrial-derived peptide MOTS-c (human observational biomarker context)",
        "year": 2021,
        "url": "https://www.nature.com/articles/s41598-021-96419-z",
        "notes": "Human observational/biomarker context; not proof of clinical benefit.",
        "id": "E3"
      },
      {
        "source_id": "E4",
        "source_type": "review",
        "evidence_grade": "mechanistic_only",
        "title": "MOTS-c: A promising mitochondrial-derived peptide (review)",
        "year": 2023,
        "url": "https://pubmed.ncbi.nlm.nih.gov/36761202/",
        "notes": "Review synthesis; use for uncertainty boundaries.",
        "id": "E4"
      },
      {
        "source_id": "E5",
        "source_type": "review",
        "evidence_grade": "mechanistic_only",
        "title": "MOTS-c, the Most Recent Mitochondrial Derived Peptide (review)",
        "year": 2022,
        "url": "https://pubmed.ncbi.nlm.nih.gov/36233287/",
        "notes": "Review synthesis; not proof of efficacy.",
        "id": "E5"
      }
    ],
    "changelog": [
      {
        "date": "2026-01-18",
        "change_type": "initial_entry",
        "summary": "Initial canonical entry for MOTS-c",
        "detail": "Generated from queue ingestion (Phase 6). Requires human-authored, evidence-bounded content.",
        "evidence_refs": []
      },
      {
        "date": "2026-01-18T19:39:10+00:00",
        "change_type": "content_update",
        "summary": "Added conservative evidence set and linked overview evidence_refs (no instructions).",
        "detail": "Inserted primary discovery paper, animal study, human observational context, and two reviews. Linked overview blocks to evidence IDs. No dosing/protocol language added.",
        "evidence_refs": [
          "E1",
          "E2",
          "E3",
          "E4",
          "E5"
        ]
      }
    ]
  }
}
